Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status

BACKGROUND: Carboplatin plus etoposide (CE) is a standard treatment for elderly patients with extensive‐disease small cell lung cancer (ED‐SCLC). However, amrubicin monotherapy (AMR) may be a feasible alternative. We compared the efficacies and safety profiles of CE and AMR for ED‐SCLC in elderly pa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thorac Cancer
Autori principali: Igawa, Satoshi, Shirasawa, Masayuki, Ozawa, Takahiro, Nishinarita, Noriko, Okuma, Yuriko, Ono, Taihei, Sugimoto, Ai, Kurahayashi, Shintaro, Sugita, Keisuke, Sone, Hideyuki, Fukui, Tomoya, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons Australia, Ltd 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6068456/
https://ncbi.nlm.nih.gov/pubmed/29870153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12772
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi